This webinar will provide Participants with firsthand insight from the pioneers of the field on how the first-hand transplants came to be and their vision for the future.
The speakers will critique the reasoning for attempting UE transplants, enumerate the steps taken prior to the first clinical cases and describe how the original teams were assembled.CLICK HERE TO SIGNUP AND LEARN MORE
The ISN-TTS Sister Transplant Centers Program is a joint partnership set up between ISN and The Transplantation Society (TTS) to create new kidney transplant centers and develop existing kidney transplant programs in emerging countries. This initiative encourages transplant centers to work together to increase opportunities for kidney transplant patients in developing countries.CLICK HERE TO LEARN MORE
Last week we released the latest webinar in the series. Dr. Philip Halloran presents on the Molecular Microscope and the unmet need for precision pathological diagnosis. This webinar is moderated by Dr. Jon Kobashigawa. Still available, last month's webinar presented by Maarten Naesens on System Biology and precision Transplantation Medicine. Log in and take advantage of writing questions to the moderators and presenters in your own time.
*Note, you must be logged in to participate.CLICK HERE TO VIEW
Dr. Joel Thomas Adler, Editorial Fellow, Transplantation
Farid SG, Attia MS, Vijayanand D; et al.
Transplantation April 2019 - Volume 103 - Issue 4 - p e79-e88.
In donation after circulatory death (DCD), the relationship of the time from aortic perfusion to hepatectomy and graft outcomes is not known. Farid and colleagues analyzed 1112 DCD donors in the UK. In multivariate analyses of graft survival, the most strongly associated factors were hepatectomy time of longer than 60 minutes, donors older than 45 years, cold ischemia time of longer than 8 hours, and previous abdominal surgery. While the impact of a prolonged hepatectomy time was found to be significant, it is one of a number of factors that impact outcomes and should not be considered in isolation.CLICK HERE TO VIEW
August 8 - What happens in the early days of organ development? How do a small group of cells organize to become a heart, a brain, or a kidney? This critical period of development has long remained the black box of developmental biology, in part because no sensor was small or flexible enough to observe this process without damaging the cells.
August 6 - It's only been seven years since scientists first learned how to precisely and reliably splice the human genome using a tool called CRISPR, making it possible to think about snipping out disease-causing mutations and actually cure, once and for all, genetic diseases ranging from sickle cell anemia to certain types of cancer and even blindness.
August 6 - The fleshy blob looks essentially like a human liver, the vital internal organ that—among many functions—aids digestion and filters blood. But it didn't come from a person. Instead, scientists crafted this mini-liver from human cells, creating the most complex organ of its kind yet grown in a lab.
August 13 - Ebola may soon be a "preventable and treatable" disease after a trial of two drugs showed significantly improved survival rates, scientists have said.
August 8 - Kidney disease is one of the leading causes of death among SCD patients. Kidney transplant is considered the best strategy to improve outcomes among the general population with kidney disease, but specific data for SCD patients is lacking. A group of researchers did a retrospective analysis of clinical and demographic parameters of 36 SCD patients who underwent kidney transplants.
The 3rd Joint Meeting of the Turkish Transplantation Society and the Turkic World Transplantation Society will be held in Tashkent, Uzbekistan on October 10-11, 2019. The Scientific and Local Organizing Committees, comprised of international transplantation leaders, have developed a program that reflects current problems and represents a collection of scientific, educational, and practical information. The meeting will be an exciting opportunity for transplant professionals to share their expertise as well as their concerns regarding the development of the field in their own countries.
SPLIT is an official section of The Transplantation Society
ITS 2019 is set for Nov. 10-13 in Clearwater Beach, Florida. Keynote speakers include Katherine High, President and Head of R&D at Spark Therapeutics, and Ronald Germain, chief of Laboratory of Immune System Biology and Lymphocyte Biology Section at the National Institute of Allergy and Infectious Diseases National Institutes of Health.